Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 162

1.

How to diagnose heart failure with preserved ejection fraction: the HFA-PEFF diagnostic algorithm: a consensus recommendation from the Heart Failure Association (HFA) of the European Society of Cardiology (ESC).

Pieske B, Tschöpe C, de Boer RA, Fraser AG, Anker SD, Donal E, Edelmann F, Fu M, Guazzi M, Lam CSP, Lancellotti P, Melenovsky V, Morris DA, Nagel E, Pieske-Kraigher E, Ponikowski P, Solomon SD, Vasan RS, Rutten FH, Voors AA, Ruschitzka F, Paulus WJ, Seferovic P, Filippatos G.

Eur J Heart Fail. 2020 Mar 5. doi: 10.1002/ejhf.1741. [Epub ahead of print]

PMID:
32133741
2.

Integrated management of atrial fibrillation in primary care: results of the ALL-IN cluster randomized trial.

van den Dries CJ, van Doorn S, Rutten FH, Oudega R, van de Leur SJCM, Elvan A, Oude Grave L, Bilo HJG, Moons KGM, Hoes AW, Geersing GJ.

Eur Heart J. 2020 Feb 29. pii: ehaa055. doi: 10.1093/eurheartj/ehaa055. [Epub ahead of print]

PMID:
32112556
3.

Sodium-glucose co-transporter 2 inhibitors and acute heart failure.

Groenewegen A, Rutten FH.

Eur J Heart Fail. 2020 Feb 18. doi: 10.1002/ejhf.1759. [Epub ahead of print] No abstract available.

PMID:
32072715
4.

Chest discomfort at night and risk of acute coronary syndrome: cross-sectional study of telephone conversations.

Wouters LT, Zwart DL, Erkelens DC, Cheung NS, de Groot E, Damoiseaux RA, Hoes AW, Rutten FH.

Fam Pract. 2020 Jan 30. pii: cmaa005. doi: 10.1093/fampra/cmaa005. [Epub ahead of print]

PMID:
31996901
5.

Opportunistic screening versus usual care for diagnosing atrial fibrillation in general practice: a cluster randomised controlled trial.

Kaasenbrood F, Hollander M, de Bruijn SH, Dolmans CP, Tieleman RG, Hoes AW, Rutten FH.

Br J Gen Pract. 2020 Jan 27. pii: bjgp20X708161. doi: 10.3399/bjgp20X708161. [Epub ahead of print]

PMID:
31988084
6.

Mortality after hospital admission for heart failure: improvement over time, equally strong in women as in men.

Buddeke J, Valstar GB, van Dis I, Visseren FLJ, Rutten FH, den Ruijter HM, Vaartjes I, Bots ML; Queen of Hearts and RECONNECT investigators.

BMC Public Health. 2020 Jan 10;20(1):36. doi: 10.1186/s12889-019-7934-3.

7.

Safety of switching from vitamin K antagonist to non-vitamin K antagonist oral anticoagulant in frail elderly with atrial fibrillation: rationale and design of the FRAIL-AF randomised controlled trial.

Joosten LPT, van Doorn S, Hoes AW, Nierman MC, Wiersma NM, Koek HL, Hemels MEW, Huisman MV, Roes KC, van den Bor RM, Buding WF, Rutten FH, Geersing GJ.

BMJ Open. 2019 Dec 29;9(12):e032488. doi: 10.1136/bmjopen-2019-032488.

8.

Tinkering and overruling the computer decision support system: Working strategies of telephone triage nurses who assess the urgency of callers suspected of having an acute cardiac event.

Wouters LT, Zwart DL, Erkelens DC, Huijsmans M, Hoes AW, Damoiseaux RA, Rutten FH, de Groot E.

J Clin Nurs. 2020 Apr;29(7-8):1175-1186. doi: 10.1111/jocn.15168. Epub 2020 Jan 23.

PMID:
31887234
9.

Clinical research study implementation of case-finding strategies for heart failure and chronic obstructive pulmonary disease in the elderly with reduced exercise tolerance or dyspnea: A cluster randomized trial.

van Mourik Y, Rutten FH, Bertens LCM, Cramer MJM, Lammers JJ, Gohar A, Reitsma JB, Moons KGM, Hoes AW.

Am Heart J. 2020 Feb;220:73-81. doi: 10.1016/j.ahj.2019.08.021. Epub 2019 Sep 1.

PMID:
31790904
10.

Age at menarche and heart failure risk: The EPIC-NL study.

Plompen MVL, van der Schouw YT, Rutten FH, Verschuren WMM, Boer JMA, Asselbergs FW, Onland-Moret NC.

Maturitas. 2020 Jan;131:34-39. doi: 10.1016/j.maturitas.2019.10.003. Epub 2019 Nov 5.

PMID:
31787145
11.

Are there gender disparities in symptom presentation or triage of patients with chest discomfort at primary care out-of-hours services? An observational study.

van der Meer MG, Appelman Y, Rutten KHG, van der Graaf Y, Nathoe HM, Doevendans PA, Smit M, Verheij E, Botermans A, Rutten FH.

BMJ Open. 2019 Nov 19;9(11):e031613. doi: 10.1136/bmjopen-2019-031613.

12.

Decelerating trends in heart failure survival.

Groenewegen A, Rutten FH.

Eur J Heart Fail. 2019 Nov;21(11):1326-1328. doi: 10.1002/ejhf.1626. No abstract available.

PMID:
31746110
13.

Diagnostic Accuracy of the Explicit Diagnostic Criteria for Transient Ischemic Attack: A Validation Study.

Dolmans LS, Lebedeva ER, Veluponnar D, van Dijk EJ, Nederkoorn PJ, Hoes AW, Rutten FH, Olesen J, Kappelle LJ; MIND-TIA Study Group.

Stroke. 2019 Aug;50(8):2080-2085. doi: 10.1161/STROKEAHA.119.025626. Epub 2019 Jun 20.

14.

Response by Dolmans et al to Letter Regarding Article, "Diagnostic Accuracy of the Explicit Diagnostic Criteria for Transient Ischemic Attack: A Validation Study".

Dolmans LS, Rutten FH, Kappelle LJ.

Stroke. 2019 Nov;50(11):e336. doi: 10.1161/STROKEAHA.119.027444. Epub 2019 Oct 18. No abstract available.

PMID:
31623541
15.

Validation and impact of a simplified clinical decision rule for diagnosing pulmonary embolism in primary care: design of the PECAN prospective diagnostic cohort management study.

van Maanen R, Rutten FH, Klok FA, Huisman MV, Blom JW, Moons KGM, Geersing GJ.

BMJ Open. 2019 Oct 10;9(10):e031639. doi: 10.1136/bmjopen-2019-031639.

16.

How to diagnose heart failure with preserved ejection fraction: the HFA-PEFF diagnostic algorithm: a consensus recommendation from the Heart Failure Association (HFA) of the European Society of Cardiology (ESC).

Pieske B, Tschöpe C, de Boer RA, Fraser AG, Anker SD, Donal E, Edelmann F, Fu M, Guazzi M, Lam CSP, Lancellotti P, Melenovsky V, Morris DA, Nagel E, Pieske-Kraigher E, Ponikowski P, Solomon SD, Vasan RS, Rutten FH, Voors AA, Ruschitzka F, Paulus WJ, Seferovic P, Filippatos G.

Eur Heart J. 2019 Oct 21;40(40):3297-3317. doi: 10.1093/eurheartj/ehz641.

PMID:
31504452
17.

Candidate Biomarkers for the Diagnosis of Transient Ischemic Attack: A Systematic Review.

Dolmans LS, Rutten FH, Koenen NCT, Bartelink MEL, Reitsma JB, Kappelle LJ, Hoes AW.

Cerebrovasc Dis. 2019;47(5-6):207-216. doi: 10.1159/000502449. Epub 2019 Aug 30. Review.

18.

Optimisation of telephone triage of callers with symptoms suggestive of acute cardiovascular disease in out-of-hours primary care: observational design of the Safety First study.

Erkelens DC, Wouters LT, Zwart DL, Damoiseaux RA, De Groot E, Hoes AW, Rutten FH.

BMJ Open. 2019 Jul 1;9(7):e027477. doi: 10.1136/bmjopen-2018-027477.

19.

Determinants of Patient Delay in Transient Ischemic Attack.

Dolmans LS, Hoes AW, Bartelink MEL, Kappelle LJ, Rutten FH; for the MIND-TIA Study Group.

Eur Neurol. 2019;81(3-4):139-144. doi: 10.1159/000501077. Epub 2019 Jun 18.

20.

Mid-regional pro-atrial natriuretic peptide for the early detection of non-acute heart failure.

Gohar A, Rutten FH, den Ruijter H, Kelder JC, von Haehling S, Anker SD, Möckel M, Hoes AW.

Eur J Heart Fail. 2019 Oct;21(10):1219-1227. doi: 10.1002/ejhf.1495. Epub 2019 Jun 17.

PMID:
31209992
21.

Discovery of biomarkers for the presence and progression of left ventricular diastolic dysfunction and HEart faiLure with Preserved ejection Fraction in patients at risk for cardiovascular disease: rationale and design of the HELPFul case-cohort study in a Dutch cardiology outpatient clinic.

Valstar GB, Bots SH, Groepenhoff F, Gohar A, Rutten FH, Leiner T, Cramer MJM, Teske AJ, Suciadi LP, Menken R, Pasterkamp G, Asselbergs FW, Hofstra L, Bots ML, den Ruijter HM.

BMJ Open. 2019 Jun 5;9(6):e028408. doi: 10.1136/bmjopen-2018-028408.

22.

Stroke Rate Variation and Anticoagulation Benefit in Atrial Fibrillation.

Joosten LPT, van Doorn S, Rutten FH, Geersing GJ.

Ann Intern Med. 2019 Jun 4;170(11):816-817. doi: 10.7326/L19-0129. No abstract available.

PMID:
31158860
23.

[Towards 'the best DOAC'?]

van Doorn S, Rutten FH, Geersing GJ.

Ned Tijdschr Geneeskd. 2019 Mar 21;163. pii: D3524. Dutch.

PMID:
30945829
24.

Delay in patients suspected of transient ischaemic attack: a cross-sectional study.

Dolmans LS, Kappelle LJ, Bartelink ME, Hoes AW, Rutten FH.

BMJ Open. 2019 Feb 27;9(2):e027161. doi: 10.1136/bmjopen-2018-027161.

25.

Misclassification of Both Chronic Obstructive Pulmonary Disease and Heart Failure.

Rutten FH, Broekhuizen BDL.

JAMA Netw Open. 2018 Dec 7;1(8):e185486. doi: 10.1001/jamanetworkopen.2018.5486. No abstract available.

26.

[Acute chest pain and normal high-sensitivity cardiac troponin levels; is this the end of the story?]

Rutten FH.

Ned Tijdschr Geneeskd. 2018 Dec 5;162. pii: D3540. Dutch.

PMID:
30570939
27.

Near-home heart failure care.

Groenewegen A, Rutten FH.

Eur J Heart Fail. 2019 Jan;21(1):110-111. doi: 10.1002/ejhf.1345. Epub 2018 Dec 6. No abstract available.

28.

Effectiveness of the European Society of Cardiology/Heart Failure Association website 'heartfailurematters.org' and an e-health adjusted care pathway in patients with stable heart failure: results of the 'e-Vita HF' randomized controlled trial.

Wagenaar KP, Broekhuizen BDL, Jaarsma T, Kok I, Mosterd A, Willems FF, Linssen GCM, Agema WRP, Anneveldt S, Lucas CMHB, Mannaerts HFJ, Wajon EMCJ, Dickstein K, Cramer MJ, Landman MAJ, Hoes AW, Rutten FH.

Eur J Heart Fail. 2019 Feb;21(2):238-246. doi: 10.1002/ejhf.1354. Epub 2018 Nov 28.

29.

Opportunistic screening models for high-risk men and women to detect diastolic dysfunction and heart failure with preserved ejection fraction in the community.

Gohar A, Kievit RF, Valstar GB, Hoes AW, Van Riet EE, van Mourik Y, Bertens LC, Boonman-Winter LJ, Bots ML, Den Ruijter HM, Rutten FH.

Eur J Prev Cardiol. 2019 Apr;26(6):613-623. doi: 10.1177/2047487318816774. Epub 2018 Nov 27.

30.

Routine primary care data for scientific research, quality of care programs and educational purposes: the Julius General Practitioners' Network (JGPN).

Smeets HM, Kortekaas MF, Rutten FH, Bots ML, van der Kraan W, Daggelders G, Smits-Pelser H, Helsper CW, Hoes AW, de Wit NJ.

BMC Health Serv Res. 2018 Sep 25;18(1):735. doi: 10.1186/s12913-018-3528-5.

31.

Effectiveness of CHA2DS2-VASc based decision support on stroke prevention in atrial fibrillation: A cluster randomised trial in general practice.

van Doorn S, Rutten FH, O'Flynn CM, Oudega R, Hoes AW, Moons KGM, Geersing GJ.

Int J Cardiol. 2018 Dec 15;273:123-129. doi: 10.1016/j.ijcard.2018.08.096. Epub 2018 Sep 8.

PMID:
30224261
32.

Risk of cardiac and non-cardiac adverse events in community-dwelling older patients with atrial fibrillation: a prospective cohort study in the Netherlands.

van Doorn S, Tavenier A, Rutten FH, Hoes AW, Moons KGM, Geersing GJ.

BMJ Open. 2018 Aug 23;8(8):e021681. doi: 10.1136/bmjopen-2018-021681.

33.

The prevalence of left ventricular diastolic dysfunction and heart failure with preserved ejection fraction in men and women with type 2 diabetes: A systematic review and meta-analysis.

Bouthoorn S, Valstar GB, Gohar A, den Ruijter HM, Reitsma HB, Hoes AW, Rutten FH.

Diab Vasc Dis Res. 2018 Nov;15(6):477-493. doi: 10.1177/1479164118787415. Epub 2018 Jul 24.

34.

Patient delay in TIA: a systematic review.

Dolmans LS, Hoes AW, Bartelink MEL, Koenen NCT, Kappelle LJ, Rutten FH.

J Neurol. 2019 May;266(5):1051-1058. doi: 10.1007/s00415-018-8977-6. Epub 2018 Jul 19.

35.

Prospective Randomized Open-label Trial to evaluate risk faCTor management in patients with Unruptured intracranial aneurysms: Study protocol.

Vergouwen MD, Rinkel GJ, Algra A, Fiehler J, Steinmetz H, Vajkoczy P, Rutten FH, Luntz S, Hänggi D, Etminan N.

Int J Stroke. 2018 Dec;13(9):992-998. doi: 10.1177/1747493018790033. Epub 2018 Jul 18.

PMID:
30019634
36.

Vascular extracellular vesicles in comorbidities of heart failure with preserved ejection fraction in men and women: The hidden players. A mini review.

Gohar A, de Kleijn DPV, Hoes AW, Rutten FH, Hilfiker-Kleiner D, Ferdinandy P, Sluijter JPG, den Ruijter HM.

Vascul Pharmacol. 2018 Dec;111:1-6. doi: 10.1016/j.vph.2018.05.006. Epub 2018 May 26. Review.

PMID:
29807165
37.

Prevalence of left ventricular systolic dysfunction and heart failure with reduced ejection fraction in men and women with type 2 diabetes mellitus: a systematic review and meta-analysis.

Bouthoorn S, Gohar A, Valstar G, den Ruijter HM, Reitsma JB, Hoes AW, Rutten FH; Queen of Hearts Consortium.

Cardiovasc Diabetol. 2018 Apr 18;17(1):58. doi: 10.1186/s12933-018-0690-3.

38.

Opportunistic screening for heart failure with natriuretic peptides in patients with atrial fibrillation: a meta-analysis of individual participant data of four screening studies.

van Doorn S, Geersing GJ, Kievit RF, van Mourik Y, Bertens LC, van Riet EES, Boonman-de Winter LJ, Moons KGM, Hoes AW, Rutten FH.

Heart. 2018 Aug;104(15):1236-1237. doi: 10.1136/heartjnl-2017-312781. Epub 2018 Mar 16.

PMID:
29549089
39.

Sex-Specific Relations of Cardiovascular Risk Factors With Left Ventricular Diastolic Dysfunction/Heart Failure With Preserved Ejection Fraction Are Underreported: A Call for Action.

Eikendal ALM, Gohar A, Rutten FH, Bots ML, Appelman Y, Hofstra L, Cramer MJM, Hoes AW, den Ruijter HM.

J Card Fail. 2018 Jun;24(6):412-414. doi: 10.1016/j.cardfail.2018.03.001. Epub 2018 Mar 13. No abstract available.

40.

Efficient selective screening for heart failure in elderly men and women from the community: A diagnostic individual participant data meta-analysis.

Kievit RF, Gohar A, Hoes AW, Bots ML, van Riet EE, van Mourik Y, Bertens LC, Boonman-de Winter LJ, den Ruijter HM, Rutten FH; Queen of Hearts and RECONNECT consortium.

Eur J Prev Cardiol. 2018 Mar;25(4):437-446. doi: 10.1177/2047487317749897. Epub 2018 Jan 12.

41.

Interpretability of the European Heart Failure Self-care Behaviour scale.

Wagenaar KP, Broekhuizen BD, Rutten FH, Strömberg A, van Stel HF, Hoes AW, Jaarsma T.

Patient Prefer Adherence. 2017 Oct 26;11:1841-1849. doi: 10.2147/PPA.S144915. eCollection 2017.

42.

The effects of misclassification in routine healthcare databases on the accuracy of prognostic prediction models: a case study of the CHA2DS2-VASc score in atrial fibrillation.

van Doorn S, Brakenhoff TB, Moons KGM, Rutten FH, Hoes AW, Groenwold RHH, Geersing GJ.

Diagn Progn Res. 2017 Nov 16;1:18. doi: 10.1186/s41512-017-0018-x. eCollection 2017.

43.

Right heart dysfunction and failure in heart failure with preserved ejection fraction: mechanisms and management. Position statement on behalf of the Heart Failure Association of the European Society of Cardiology.

Gorter TM, van Veldhuisen DJ, Bauersachs J, Borlaug BA, Celutkiene J, Coats AJS, Crespo-Leiro MG, Guazzi M, Harjola VP, Heymans S, Hill L, Lainscak M, Lam CSP, Lund LH, Lyon AR, Mebazaa A, Mueller C, Paulus WJ, Pieske B, Piepoli MF, Ruschitzka F, Rutten FH, Seferovic PM, Solomon SD, Shah SJ, Triposkiadis F, Wachter R, Tschöpe C, de Boer RA.

Eur J Heart Fail. 2018 Jan;20(1):16-37. doi: 10.1002/ejhf.1029. Epub 2017 Oct 16. Review.

44.

Integrated management of atrial fibrillation including tailoring of anticoagulation in primary care: study design of the ALL-IN cluster randomised trial.

van den Dries CJ, Oudega R, Elvan A, Rutten FH, van de Leur SJCM, Bilo HJG, Hoes AW, Moons KGM, Geersing GJ.

BMJ Open. 2017 Sep 18;7(9):e015510. doi: 10.1136/bmjopen-2016-015510.

45.

'heartfailurematters.org', an educational website for patients and carers from the Heart Failure Association of the European Society of Cardiology: objectives, use and future directions.

Wagenaar KP, Rutten FH, Klompstra L, Bhana Y, Sieverink F, Ruschitzka F, Seferovic PM, Lainscak M, Piepoli MF, Broekhuizen BDL, Strömberg A, Jaarsma T, Hoes AW, Dickstein K.

Eur J Heart Fail. 2017 Nov;19(11):1447-1454. doi: 10.1002/ejhf.917. Epub 2017 Sep 4. Review.

46.

What the General Practitioner Needs to Know About Their Chronic Heart Failure Patient.

Rutten FH, Gallagher J.

Card Fail Rev. 2016 Nov;2(2):79-84. doi: 10.15420/cfr.2016:18:1.

47.

Practical guidance on heart failure diagnosis and management in primary care: recent EPCCS recommendations.

Taylor CJ, Rutten FH, Brouwer JR, Hobbs FR.

Br J Gen Pract. 2017 Jul;67(660):326-327. doi: 10.3399/bjgp17X691553. No abstract available.

48.

Predictive performance of the CHA2DS2-VASc rule in atrial fibrillation: a systematic review and meta-analysis.

van Doorn S, Debray TPA, Kaasenbrood F, Hoes AW, Rutten FH, Moons KGM, Geersing GJ.

J Thromb Haemost. 2017 Jun;15(6):1065-1077. doi: 10.1111/jth.13690. Epub 2017 May 9. Review.

49.

2016 ESC Guidelines for the Diagnosis and Treatment of Acute and Chronic Heart Failure.

Ponikowski P, Voors AA, Anker SD, Bueno H, Cleland JGF, Coats AJS, Falk V, González-Juanatey JR, Harjola VP, Jankowska EA, Jessup M, Linde C, Nihoyannopoulos P, Parissis JT, Pieske B, Riley JP, Rosano GMC, Ruilope LM, Ruschitzka F, Rutten FH, van der Meer P.

Rev Esp Cardiol (Engl Ed). 2016 Dec;69(12):1167. doi: 10.1016/j.rec.2016.11.005. English, Spanish. No abstract available. Erratum in: Rev Esp Cardiol (Engl Ed). 2017 Apr;70(4):309-310.

PMID:
27894487
50.

Frequency and prognostic impact of mid-expiratory flow reduction in stable patients six months after hospitalisation for heart failure with reduced ejection fraction.

Brenner S, Christa M, Berliner D, Deubner N, Ertl G, Held M, Marx A, Angermann CE, Störk S, Rutten FH, Güder G.

Int J Cardiol. 2017 Jan 15;227:727-733. doi: 10.1016/j.ijcard.2016.10.071. Epub 2016 Oct 28.

PMID:
27816302

Supplemental Content

Loading ...
Support Center